A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older
Clinical trial NCT06744205 · COMPLETED
Trial details
- NCT number
- NCT06744205
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2026-05-22
- Enrollment
- 1162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.